business

The Wegovy pill is still dominating the GLP-1 pill market

MarketWatch · Jun 7, 2026, 11:35 PM · Also reported by 1 other source

It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.

Read full story on MarketWatch → More top stories

Also covered by

Yahoo Finance Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now?

Aggregated and edited by the Scoop newsroom. We surface news from MarketWatch alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

The Wegovy pill is still dominating the GLP-1 pill market

Also covered by

More in business